{"entity":{"id":"nct07823322","kind":"trial","name":"A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection a","aka":["NEXERA-204"],"tldr":"A phase 2 trial of INCA33890 in colorectal cancer, run by Incyte Corporation, not yet recruiting.","summary":"A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy is a phase 2, interventional study registered as NCT07823322 by Incyte Corporation, with a registry enrolment figure of 40 participants, started 2026-10-26 and due to reach its primary completion in 2029-05-14. Interventions recorded: INCA33890. Conditions listed: CRC (Colorectal Cancer). Primary outcome: Circulating tumor DNA (ctDNA) clearance. Colorectal eligibility wording from the registry: \"* Received curative-intent (R0) resection of histologically confirmed Stage II or III colorectal adenocarcinoma\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07823322","url":"https://clinicaltrials.gov/study/NCT07823322"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":["mrd-testing"],"targets":[],"drugs":["inca33890"],"companies":["incyte"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07823322","phase":"2","setting":"A Phase 2 Study of INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy (NEXERA-204)","sponsor":"Incyte Corporation","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07823322/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"technology":[{"id":"mrd-testing","kind":"technology","name":"MRD / molecular residual disease testing","route":"/technologies/mrd-testing/"}],"drug":[{"id":"inca33890","kind":"drug","name":"INCA33890","route":"/drugs/inca33890/"}],"company":[{"id":"incyte","kind":"company","name":"Incyte","route":"/companies/incyte/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}